Literature DB >> 21946282

Clinicopathologic features of intraductal papillary neoplasm of the bile duct according to histologic subtype.

Kwang Min Kim1, Jong Kyun Lee, Jae Uk Shin, Kwang Hyuck Lee, Kyu Taek Lee, Ji-Youn Sung, Kee-Taek Jang, Jin Seok Heo, Seong-Ho Choi, Dong Wook Choi, Jae Hoon Lim.   

Abstract

OBJECTIVES: Despite an increase in the reports of intraductal papillary neoplasm of the bile duct (IPN-B), the clinical characteristics and long-term prognosis of this disease are not well known compared with those of intraductal papillary mucinous neoplasms of the pancreas. The objective of our study was to compare the clinical features, radiologic findings, and clinical outcomes of IPN-B according to histologic subtype.
METHODS: A retrospective analysis was performed on the medical records of 97 patients diagnosed with IPN-B by pathologic analysis of their surgical specimens between May 1995 and May 2010. We compared the clinical manifestations, radiological findings, pathologic grade, curative resection rate, recurrence, and overall survival according to four histologic subtypes: gastric (n=15), intestinal (n=46), pancreaticobiliary (n=33), and oncocytic (n=3), which were classified on the basis of hematoxylin and eosin staining and the immunohistochemical profile of mucin core proteins.
RESULTS: Mucin hypersecretion was significantly more frequent in patients with gastric and intestinal types than it was in those with oncocytic and pancreaticobiliary types (P=0.014). There were no significant differences between groups regarding the presence of bile duct stones or tumor location. The frequency of invasive carcinoma in the pancreaticobiliary type was significantly higher than those in the gastric and intestinal types (72.7 vs. 26.7 and 32.6%, P<0.001 and P<0.001). When comparing the survival curves according to histologic subtype, patients with pancreaticobiliary type demonstrated significantly worse survival compared to those with gastric and intestinal types (P=0.035).
CONCLUSIONS: Gastric and intestinal types of IPN-B have similar clinical characteristics compared with the pancreaticobiliary type, which has a worse prognosis.

Entities:  

Mesh:

Year:  2011        PMID: 21946282     DOI: 10.1038/ajg.2011.316

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  37 in total

1.  Clinical and pathological features of intraductal papillary neoplasm of the biliary tract and gallbladder.

Authors:  Sean Bennett; E Celia Marginean; Melanie Paquin-Gobeil; Jason Wasserman; Joel Weaver; Richard Mimeault; Fady K Balaa; Guillaume Martel
Journal:  HPB (Oxford)       Date:  2015-09       Impact factor: 3.647

2.  Haemostatic radiation therapy for a bleeding intraductal papillary neoplasm of the biliary tree.

Authors:  Senthil Sundaravadanan; Manu Mathew; Thomas Samuel Ram; Philip Joseph
Journal:  BMJ Case Rep       Date:  2018-12-14

3.  Clinicopathological significance of mucin production in patients with papillary cholangiocarcinoma.

Authors:  Shunsuke Onoe; Yoshie Shimoyama; Tomoki Ebata; Yukihiro Yokoyama; Tsuyoshi Igami; Gen Sugawara; Takashi Mizuno; Shigeo Nakamura; Masato Nagino
Journal:  World J Surg       Date:  2015-05       Impact factor: 3.352

4.  Morphological classification of intraductal papillary neoplasm of the bile duct.

Authors:  Shihong Ying; Mingliang Ying; Wenjie Liang; Zhaoming Wang; Qidong Wang; Feng Chen; Wenbo Xiao
Journal:  Eur Radiol       Date:  2017-11-14       Impact factor: 5.315

5.  Ruptured intrahepatic biliary intraductal papillary mucinous neoplasm in a Jehovah's Witness patient.

Authors:  Sangchul Yun; Dongho Choi
Journal:  Int Surg       Date:  2014 Sep-Oct

6.  Biliary tract intraductal papillary mucinous neoplasm: report of 19 cases.

Authors:  Xing Wang; Yun-Qiang Cai; Yong-Hua Chen; Xu-Bao Liu
Journal:  World J Gastroenterol       Date:  2015-04-14       Impact factor: 5.742

7.  CK20 and lymph node involvement predict adverse outcome of malignant intraductal papillary neoplasm of the bile duct.

Authors:  Jie Shi; Xueshuai Wan; Yuan Xie; Jianzhen Lin; Junyu Long; Weiyu Xu; Zhiyong Liang; Xinting Sang; Haitao Zhao
Journal:  Histol Histopathol       Date:  2019-10-28       Impact factor: 2.303

Review 8.  [Intraductal papillary neoplasms of the bile duct (IPNB). Diagnostic criteria, carcinogenesis and differential diagnostics].

Authors:  A M Schlitter; G Klöppel; I Esposito
Journal:  Pathologe       Date:  2013-11       Impact factor: 1.011

9.  Clinicopathological characterization of so-called "cholangiocarcinoma with intraductal papillary growth" with respect to "intraductal papillary neoplasm of bile duct (IPNB)".

Authors:  Yasuni Nakanuma; Yasunori Sato; Hidenori Ojima; Yae Kanai; Shinichi Aishima; Masakazu Yamamoto; Shun-ichi Ariizumi; Toru Furukawa; Hiroki Hayashi; Michiaki Unno; Tetsuo Ohta
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

10.  A case of cystic intraductal papillary neoplasm of the bile duct with associated adenocarcinoma.

Authors:  Masakuni Fujii; Yuki Okamoto; Junji Shiode
Journal:  Clin J Gastroenterol       Date:  2019-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.